Publications published since 2000 from OUS - Department of Urology

273 publications found

Publications 2020

  1. Berger I, Berland S, Rodriguez JR, Aamodt H, Sitek JC, Jørgensen K, Johansen TEB (2020)
    Tidsskr Nor Laegeforen, 140 (6)
    DOI 10.4045/tidsskr.18.0848, PubMed 32321218
  2. Berger I, Aamodt H, Jorgensen K, Berland S, Sitek JC, Johansen TEB, Rodriguez JR (2020)
    Tidsskr. Nor. Laegeforen., 140 (6), 565-569
  3. Cai T, Cocci A, Gacci M, Verze P, Bonkat G, Koves B, Wagenlehner F, Bartoletti R, Bjerklund Johansen TE (2020)
    Guidelines in urology: Lights and shadows
    Urologia, UNSP 0391560320917805
    DOI 10.1177/0391560320917805, PubMed 32342733
  4. Cai T, Tamanini I, Mattevi D, Verze P, Palmieri A, Malossini G, Mirone V, Novelli A, Tascini C, Johansen TEB (2020)
    Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study
    Int J Antimicrob Agents, 105935 (in press)
    DOI 10.1016/j.ijantimicag.2020.105935, PubMed 32156620
  5. Cai T, Verze P, Luciani L, Malossini G, Bjerklund Johansen TE, Benettollo PP, Guarrera GM (2020)
    What do patients say about telephone-based urological consultations at the time of the COVID-19 pandemic?
    Minerva Urol Nefrol (in press)
    DOI 10.23736/S0393-2249.20.03940-5, PubMed 32432439
  6. Dahl AA, Brennhovd B, Fosså SD, Axcrona K (2020)
    A cross-sectional study of current work ability after radical prostatectomy
    BMC Urol, 20 (1), 9
    DOI 10.1186/s12894-020-0579-9, PubMed 32005115
  7. Grummet J, Gorin MA, Popert R, O'Brien T, Lamb AD, Hadaschik B, Radtke JP, Wagenlehner F, Baco E, Moore CM, Emberton M, George AK, Davis JW, Szabo RJ, Buckley R, Loblaw A, Allaway M, Kastner C, Briers E, Royce PL, Frydenberg M, Murphy DG, Woo HH (2020)
    "TREXIT 2020": why the time to abandon transrectal prostate biopsy starts now
    Prostate Cancer Prostatic Dis, 23 (1), 62-65
    DOI 10.1038/s41391-020-0204-8, PubMed 31932659

Publications 2019

  1. Cai T, Cocci A, Coccarelli F, Ruggera L, Lanzafame P, Caciagli P, Malossini G, Crisci A, Trinchieri A, Perletti G, Carini M, Bonkat G, Bartoletti R, Bjerklund Johansen TE (2019)
    Infectious Complications After Laser Vaporization of Urinary Stones During Retrograde Intrarenal Surgery Are Not Associated with Spreading of Bacteria into Irrigation Fluid but with Previous Use of Fluoroquinolones
    Eur Urol Focus (in press)
    DOI 10.1016/j.euf.2019.02.018, PubMed 30853604
  2. Cai T, Santi R, Tamanini I, Galli IC, Perletti G, Bjerklund Johansen TE, Nesi G (2019)
    Current Knowledge of the Potential Links between Inflammation and Prostate Cancer
    Int J Mol Sci, 20 (15)
    DOI 10.3390/ijms20153833, PubMed 31390729
  3. Cai T, Tamanini I, Cocci A, Di Maida F, Caciagli P, Migno S, Mereu L, Tateo S, Malossini G, Palmieri A, Verze P, Mirone V, Bjerklund Johansen TE (2019)
    Xyloglucan, hibiscus and propolis to reduce symptoms and antibiotics use in recurrent UTIs: a prospective study
    Future Microbiol, 14, 1013-1021
    DOI 10.2217/fmb-2019-0145, PubMed 31469009
  4. Cai T, Tamanini I, Tascini C, Köves B, Bonkat G, Gacci M, Novelli A, Horcajada JP, Bjerklund Johansen TE, Zanel G (2019)
    Fosfomycin Trometamol versus Comparator Antibiotics for the Treatment of Acute Uncomplicated Urinary Tract Infections in Women: A Systematic Review and Meta-Analysis
    J Urol, 203 (3), 570-578
    DOI 10.1097/JU.0000000000000620, PubMed 31651226
  5. Cai T, Tamanini I, Tascini C, Köves B, Bonkat G, Gacci M, Novelli A, Horcajada JP, Bjerklund Johansen TE, Zanel G (2019)
    Reply by Authors
    J Urol, 203 (3), 578
    DOI 10.1097/JU.0000000000000620.03, PubMed 31854257
  6. Dixon M, Stefil M, McDonald M, Bjerklund-Johansen TE, Naber K, Wagenlehner F, Mouraviev V (2019)
    Metagenomics in diagnosis and improved targeted treatment of UTI
    World J Urol, 38 (1), 35-43
    DOI 10.1007/s00345-019-02731-9, PubMed 30944967
  7. Ersvaer E, Hveem TS, Vlatkovic L, Brennhovd B, Kleppe A, Tobin KAR, Pradhan M, Cyll K, Waehre H, Kerr DJ, Danielsen HE (2019)
    Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer
    Int J Cancer
    DOI 10.1002/ijc.32832, PubMed 31846064
  8. Gerdtsson A, Håkansson U, Törnblom M, Jancke G, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Haugnes HS, Andreassen KE, Larsen SM, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2019)
    Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group
    Eur Urol Oncol (in press)
    DOI 10.1016/j.euo.2019.08.002, PubMed 31506250
  9. Johansen TEB, Zahl PH, Baco E, Bartoletti R, Bonkat G, Bruyere F, Cai T, Cek M, Kulchavenya E, Köves B, Mouraviev V, Pilatz A, Tandogdu Z, Tenke P, Wagenlehner FME (2019)
    Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry
    World J Urol, 38 (1), 17-26
    DOI 10.1007/s00345-019-02837-0, PubMed 31183524
  10. Rud E, Galtung KF, Lauritzen PM, Baco E, Flatabø T, Sandbæk G (2019)
    Examining the upper urinary tract in patients with hematuria-time to revise the CT urography protocol?
    Eur Radiol, 30 (3), 1664-1670
    DOI 10.1007/s00330-019-06521-0, PubMed 31748856
  11. Rud E, Langberg CW, Baco E, Lauritzen P, Sandbæk G (2019)
    MRI in the Follow-up of Testicular Cancer: Less is More
    Anticancer Res, 39 (6), 2963-2968
    DOI 10.21873/anticanres.13427, PubMed 31177136
  12. Tandogdu Z, Kakariadis ETA, Naber K, Wagenlehner F, Bjerklund Johansen TE (2019)
    Appropriate empiric antibiotic choices in health care associated urinary tract infections in urology departments in Europe from 2006 to 2015: A Bayesian analytical approach applied in a surveillance study
    PLoS One, 14 (4), e0214710
    DOI 10.1371/journal.pone.0214710, PubMed 31022187
  13. Tandogdu Z, Koves B, Cai T, Cek M, Tenke P, Naber K, Wagenlehner F, Johansen TEB (2019)
    Condition-specific surveillance in health care-associated urinary tract infections as a strategy to improve empirical antibiotic treatment: an epidemiological modelling study
    World J Urol, 38 (1), 27-34
    DOI 10.1007/s00345-019-02963-9, PubMed 31555835
  14. Zhou W, Ma L, Yang J, Qiao H, Li L, Guo Q, Ma J, Zhao L, Wang J, Jiang G, Wan X, Adam Goscinski M, Ding L, Zheng Y, Li W, Liu H, Suo Z, Zhao W (2019)
    Potent and specific MTH1 inhibitors targeting gastric cancer
    Cell Death Dis, 10 (6), 434
    DOI 10.1038/s41419-019-1665-3, PubMed 31164636

Publications 2018

  1. Bartoletti R, Wagenlehner FME, Bjerklund Johansen TE, Köves B, Cai T, Tandogdu Z, Bonkat G (2018)
    Management of Urethritis: Is It Still the Time for Empirical Antibiotic Treatments?
    Eur Urol Focus, 5 (1), 29-35
    DOI 10.1016/j.euf.2018.10.006, PubMed 30318465
  2. Bjerklund Johansen TE, Cai T (2018)
    Re: Determinants of Variable Resource Use for Multidisciplinary Team Meetings in Cancer Care
    Eur Urol, 75 (1), 195
    DOI 10.1016/j.eururo.2018.10.037, PubMed 30391077
  3. Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB (2018)
    Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
    Br J Cancer, 118 (6), e11
    DOI 10.1038/bjc.2017.470, PubMed 29462127
  4. Cai T, Cocci A, Tiscione D, Puglisi M, Di Maida F, Malossini G, Verze P, Palmieri A, Mirone V, Bjerklund Johansen TE (2018)
    L-Methionine associated with Hibiscus sabdariffa and Boswellia serrata extracts are not inferior to antibiotic treatment for symptoms relief in patients affected by recurrent uncomplicated urinary tract infections: Focus on antibiotic-sparing approach
    Arch Ital Urol Androl, 90 (2), 97-100
    DOI 10.4081/aiua.2018.2.97, PubMed 29974725
  5. Cai T, Cocci A, Verze P, Rizzo M, Palmieri A, Liguori G, Trombetta C, Adembri C, Carini M, Bartoletti R, Wagenlehner FM, Bonkat G, Mirone V, Bjerklund Johansen TE, Novelli A (2018)
    The use of oral fosfomycin-trometamol in patients with catheter-associated urinary tract infections (CAUTI): new indications for an old antibiotic?
    J Chemother, 30 (5), 290-295
    DOI 10.1080/1120009X.2018.1500110, PubMed 30843774
  6. Cai T, Lanzafame P, Caciagli P, Migno S, Mereu L, Mattevi D, Luciani LG, Tateo S, Malossini G, Bjerklund Johansen TE (2018)
    Role of increasing leukocyturia for detecting the transition from asymptomatic bacteriuria to symptomatic infection in women with recurrent urinary tract infections: A new tool for improving antibiotic stewardship
    Int J Urol, 25 (9), 800-806
    DOI 10.1111/iju.13723, PubMed 30008180
  7. Cai T, Tessarolo F, Caola I, Piccoli F, Nollo G, Caciagli P, Mazzoli S, Palmieri A, Verze P, Malossini G, Mirone V, Bjerklund Johansen TE (2018)
    Prostate calcifications: A case series supporting the microbial biofilm theory
    Investig Clin Urol, 59 (3), 187-193
    DOI 10.4111/icu.2018.59.3.187, PubMed 29744476
  8. Fan ZR, Li LF, Li XL, Zhang M, Zhong YL, Li YQ, Yu DD, Cao J, Zhao J, Deng XM, Zhang MZ, Wen JG, Liu ZS, Goscinski MA, Berge V, Nesland JM, Suo ZH (2018)
    Generation of an oxoglutarate dehydrogenase knockout rat model and the effect of a high-fat diet
    RSC Adv., 8 (30), 16636-16644
  9. Hompland T, Hole KH, Ragnum HB, Aarnes EK, Vlatkovic L, Lie AK, Patzke S, Brennhovd B, Seierstad T, Lyng H (2018)
    Combined MR Imaging of Oxygen Consumption and Supply Reveals Tumor Hypoxia and Aggressiveness in Prostate Cancer Patients
    Cancer Res, 78 (16), 4774-4785
    DOI 10.1158/0008-5472.CAN-17-3806, PubMed 29945958
  10. Jain S, Lyons CA, Walker SM, McQuaid S, Hynes SO, Mitchell DM, Pang B, Logan GE, McCavigan AM, O'Rourke D, McArt DG, McDade SS, Mills IG, Prise KM, Knight LA, Steele CJ, Medlow PW, Berge V, Katz B, Loblaw DA, Harkin DP, James JA, O'Sullivan JM, Kennedy RD, Waugh DJ (2018)
    Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy
    Ann Oncol, 29 (1), 215-222
    DOI 10.1093/annonc/mdx637, PubMed 29045551
  11. Johnson I, Ottosson F, Diep LM, Berg RE, Hoff JR, Wessel N, Eri LM, Berge V (2018)
    Switching from laparoscopic radical prostatectomy to robot assisted laparoscopic prostatectomy: comparing oncological outcomes and complications
    Scand J Urol, 52 (2), 116-121
    DOI 10.1080/21681805.2017.1420099, PubMed 29334304
  12. Kløw NE, Grøtta OJ, Bay D, Sandbæk G, Johansen TEB, Hagen T, Baco E (2018)
    Outcome after prostatic artery embolization in patients with symptomatic benign prostatic hyperplasia
    Acta Radiol, 60 (9), 1175-1180
    DOI 10.1177/0284185118813709, PubMed 30450921
  13. Mariathasan AB, Boye K, Giercksky KE, Brennhovd B, Gullestad HP, Emblemsvåg HL, Grøholt KK, Dueland S, Flatmark K, Larsen SG (2018)
    Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement
    Eur J Surg Oncol, 44 (8), 1226-1232
    DOI 10.1016/j.ejso.2018.03.029, PubMed 29691115
  14. Medlow PW, Steele CJ, McCavigan AM, Reardon W, Brown CM, Lambe SM, Ishiy FAA, Walker SM, Logan GE, Raji OY, Berge V, Katz B, Kay EW, Sheehan K, Watson RW, Harkin DP, Kennedy RD, Knight LA (2018)
    Analytical validation of a prognostic prostate cancer gene expression assay using formalin fixed paraffin embedded tissue
    BMC Med Genomics, 11 (1), 125
    DOI 10.1186/s12920-018-0442-y, PubMed 30591067
  15. Oderda M, Marra G, Albisinni S, Altobelli E, Baco E, Beatrici V, Cantiani A, Carbone A, Ciccariello M, Descotes JL, Dubreuil-Chambardel M, Eldred-Evans D, Fasolis G, Ferriero M, Fiard G, Forte V, Giacobbe A, Kumar P, Lacetera V, Mozer P, Muto G, Papalia R, Pastore A, Peltier A, Piechaud T et al. (2018)
    Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients
    Int J Urol, 25 (12), 990-997
    DOI 10.1111/iju.13796, PubMed 30187529
  16. Prencipe M, Fabre A, Murphy TB, Vargyas E, O'Neill A, Bjartell A, Tasken KA, Grytli HH, Svindland A, Berge V, Eri LM, Gallagher W, Watson RW (2018)
    Role of serum response factor expression in prostate cancer biochemical recurrence
    Prostate, 78 (10), 724-730
    DOI 10.1002/pros.23516, PubMed 29608018
  17. Rud E, Diep L, Baco E (2018)
    A prospective study evaluating indirect MRI-signs for the prediction of extraprostatic disease in patients with prostate cancer: tumor volume, tumor contact length and tumor apparent diffusion coefficient
    World J Urol, 36 (4), 629-637
    DOI 10.1007/s00345-018-2171-4, PubMed 29349572
  18. Rud E, Lauritzen P, Baco E (2018)
    Re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722-8
    Eur Urol, 75 (4), e103
    DOI 10.1016/j.eururo.2018.11.047, PubMed 30528223
  19. Stranne J, Brasso K, Brennhovd B, Johansson E, Jäderling F, Kouri M, Lilleby W, Meidahl Petersen P, Mirtti T, Pettersson A, Rannikko A, Thellenberg C, Akre O (2018)
    SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer
    Scand J Urol, 52 (5-6), 313-320
    DOI 10.1080/21681805.2018.1520295, PubMed 30585526
  20. Zuber V, Jönsson EG, Frei O, Witoelar A, Thompson WK, Schork AJ, Bettella F, Wang Y, Djurovic S, Smeland OB, Dieset I, Fanous AH, Desikan RS, Küry S, Bézieau S, Dale AM, Mills IG, Andreassen OA (2018)
    Identification of shared genetic variants between schizophrenia and lung cancer
    Sci Rep, 8 (1), 674
    DOI 10.1038/s41598-017-16481-4, PubMed 29330379
  21. Aas K, Fosså SD, Kvåle R, Møller B, Myklebust TÅ, Vlatkovic L, Müller S, Berge V (2018)
    Is time from diagnosis to radical prostatectomy associated with oncological outcomes?
    World J Urol, 37 (8), 1571-1580
    DOI 10.1007/s00345-018-2570-6, PubMed 30483947

Publications 2017

  1. Ahmed HU, Berge V, Bottomley D, Cross W, Heer R, Kaplan R, Leslie T, Parker C, Relton C, Stephens R, Sydes MR, Turnbull L, van der Meulen J, Vickers A, Wilt T, Emberton M, and the Prostate Cancer RCT Consensus Group (2017)
    Corrigendum: Can we deliver randomized trials of focal therapy in prostate cancer?
    Nat Rev Clin Oncol (in press)
    DOI 10.1038/nrclinonc.2017.86, PubMed 28895571
  2. Axcrona K, Nilsson R, Brennhovd B, Sørebø Ø, Fosså SD, Dahl AA (2017)
    Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations
    BMC Urol, 17 (1), 111
    DOI 10.1186/s12894-017-0302-7, PubMed 29197360
  3. Bilir B, Sharma NV, Lee J, Hammarstrom B, Svindland A, Kucuk O, Moreno CS (2017)
    Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer
    Int J Oncol, 51 (1), 223-234
    DOI 10.3892/ijo.2017.4017, PubMed 28560383
  4. Bjerklund Johansen TE, Cai T (2017)
    Re: Women with Symptoms of a Urinary Tract Infection but a Negative Urine Culture: PCR-based Quantification of Escherichia coli Suggests Infection in Most Cases
    Eur Urol, 72 (4), 651-652
    DOI 10.1016/j.eururo.2017.05.043, PubMed 28602203
  5. Bonkat G, Braissant O, Cai T, Köves B, Bjerklund Johansen TE, Pickard R, Veeratterapillay R (2017)
    Non-molecular Methods to Detect Bacteriuria Prior to Urological Interventions: A Diagnostic Accuracy Systematic Review
    Eur Urol Focus, 3 (6), 535-537
    DOI 10.1016/j.euf.2018.03.004, PubMed 29627196
  6. Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB (2017)
    Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
    Br J Cancer, 117 (11), 1656-1664
    DOI 10.1038/bjc.2017.346, PubMed 28972967
  7. Cai T, Bjerklund Johansen TE (2017)
    Reply by the Authors
    Urology, 104, 246
    DOI 10.1016/j.urology.2017.03.025, PubMed 28366699
  8. Cai T, Koves B, Johansen TE (2017)
    Asymptomatic bacteriuria, to screen or not to screen - and when to treat?
    Curr Opin Urol, 27 (2), 107-111
    DOI 10.1097/MOU.0000000000000368, PubMed 27906777
  9. Cai T, Tamanini I, Kulchavenya E, Perepanova T, Köves B, Wagenlehner FM, Tandogdu Z, Bonkat G, Bartoletti R, Bjerklund Johansen TE (2017)
    The role of nutraceuticals and phytotherapy in the management of urinary tract infections: What we need to know?
    Arch Ital Urol Androl, 89 (1), 1-6
    DOI 10.4081/aiua.2017.1.1, PubMed 28403585
  10. Idland AV, Wyller TB, Støen R, Eri LM, Frihagen F, Ræder J, Chaudhry FA, Hansson O, Zetterberg H, Blennow K, Bogdanovic N, Brækhus A, Watne LO (2017)
    Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium
    J Alzheimers Dis, 55 (1), 371-379
    DOI 10.3233/JAD-160461, PubMed 27662296
  11. Li X, Grigalavicius M, Li Y, Li X, Zhong Y, Huang R, Yu D, Berge V, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2017)
    MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cells
    Tumour Biol, 39 (8), 1010428317713671
    DOI 10.1177/1010428317713671, PubMed 28789597
  12. Li X, Han G, Li X, Kan Q, Fan Z, Li Y, Ji Y, Zhao J, Zhang M, Grigalavicius M, Berge V, Goscinski MA, Nesland JM, Suo Z (2017)
    Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells
    Oncotarget, 8 (28), 46363-46380
    DOI 10.18632/oncotarget.18199, PubMed 28624784
  13. Li X, Lu J, Kan Q, Li X, Fan Q, Li Y, Huang R, Slipicevic A, Dong HP, Eide L, Wang J, Zhang H, Berge V, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2017)
    Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
    Sci Rep, 7 (1), 5081
    DOI 10.1038/s41598-017-05086-6, PubMed 28698547
  14. McDonald M, Kameh D, Johnson ME, Johansen TEB, Albala D, Mouraviev V (2017)
    A Head-to-Head Comparative Phase II Study of Standard Urine Culture and Sensitivity Versus DNA Next-generation Sequencing Testing for Urinary Tract Infections
    Rev Urol, 19 (4), 213-220
    DOI 10.3909/riu0780, PubMed 29472825
  15. Walker SM, Knight LA, McCavigan AM, Logan GE, Berge V, Sherif A, Pandha H, Warren AY, Davidson C, Uprichard A, Blayney JK, Price B, Jellema GL, Steele CJ, Svindland A, McDade SS, Eden CG, Foster C, Mills IG, Neal DE, Mason MD, Kay EW, Waugh DJ, Harkin DP, Watson RW et al. (2017)
    Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology
    Eur Urol, 72 (4), 509-518
    DOI 10.1016/j.eururo.2017.03.027, PubMed 28408174
  16. Aas K, Axcrona K, Kvåle R, Møller B, Myklebust TÅ, Axcrona U, Berge V, Fosså SD (2017)
    Ten-year Mortality in Men With Nonmetastatic Prostate Cancer in Norway
    Urology, 110, 140-147
    DOI 10.1016/j.urology.2017.07.048, PubMed 28823634

Publications 2016

  1. Andreassen BK, Aagnes B, Gislefoss R, Andreassen M, Wahlqvist R (2016)
    Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014
    BMC Cancer, 16 (1), 799
    DOI 10.1186/s12885-016-2832-x, PubMed 27737647
  2. Baco E, Rud E, Vlatkovic L (2016)
    Reply to Yi Zhou, Weigang Yan, and Hanzhong Li's Letter to the Editor re: Eduard Baco, Erik Rud, Lars Magne Eri, et al. A Randomized Controlled Trial to Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Eur Urol 2016;69:149-56
    Eur Urol, 70 (2), e55
    DOI 10.1016/j.eururo.2016.01.031, PubMed 26852076
  3. Bigot P, Bernhard JC, Flamand V, Gill I, Verhoest G, Beauval JB, Nouhaud FX, Suer E, Ploussard G, Hetet JF, Rigaud J, Baco E, Larré S, Sebe P, Koutlidis N, Descazeaud A, Eto M, Doerfler A, Roupret M, Vuong NS, Reix B, Matsugasumi T, Bakri AE, Albiges L, Soulié M et al. (2016)
    Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes
    Urol Oncol, 35 (1), 35.e15-35.e19
    DOI 10.1016/j.urolonc.2016.08.012, PubMed 27692834
  4. Bjerklund Johansen TE, Bonkat G, Cai T, Tandogdu Z, Wagenlehner F, Grabe M (2016)
    Grey Zones in the Field of Urinary Tract Infections
    Eur Urol Focus, 2 (4), 460-462
    DOI 10.1016/j.euf.2016.03.012, PubMed 28723480
  5. Bokhorst LP, Lepistö I, Kakehi Y, Bangma CH, Pickles T, Valdagni R, Alberts AR, Semjonow A, Strölin P, Montesino MF, Berge V, Roobol MJ, Rannikko A (2016)
    Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study
    BJU Int, 118 (3), 366-71
    DOI 10.1111/bju.13410, PubMed 26765682
  6. Braadland PR, Grytli HH, Ramberg H, Katz B, Kellman R, Gauthier-Landry L, Fazli L, Krobert KA, Wang W, Levy FO, Bjartell A, Berge V, Rennie PS, Mellgren G, Mælandsmo GM, Svindland A, Barbier O, Taskén KA (2016)
    Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism
    Oncotarget, 7 (2), 1878-94
    DOI 10.18632/oncotarget.6479, PubMed 26646591
  7. Cai T, Bonkat G, Tandogdu Z, Bartoletti R, Wagenlehner FME, Grabe M, Johansen TEB (2016)
    How to Use Antimicrobial Prophylaxis in Urological Procedures
    Eur Urol Focus, 2 (4), 348-350
    DOI 10.1016/j.euf.2016.02.010, PubMed 28723464
  8. Cai T, Gallelli L, Cocci A, Tiscione D, Verze P, Lanciotti M, Vanacore D, Rizzo M, Gacci M, Saleh O, Malossini G, Liguori G, Trombetta C, Rocco D, Palmieri A, Bartoletti R, Carini M, Wagenlehner FM, Naber K, Mirone V, Bjerklund Johansen TE (2016)
    Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative
    World J Urol, 35 (2), 221-228
    DOI 10.1007/s00345-016-1867-6, PubMed 27246847
  9. Cai T, Mazzoli S, Lanzafame P, Caciagli P, Malossini G, Nesi G, Wagenlehner FM, Köves B, Pickard R, Grabe M, Bjerklund Johansen TE, Bartoletti R (2016)
    Asymptomatic Bacteriuria in Clinical Urological Practice: Preoperative Control of Bacteriuria and Management of Recurrent UTI
    Pathogens, 5 (1)
    DOI 10.3390/pathogens5010004, PubMed 26742080
  10. Cai T, Verze P, Palmieri A, Gacci M, Lanzafame P, Malossini G, Nesi G, Bonkat G, Wagenlehner FM, Mirone V, Bartoletti R, Johansen TE (2016)
    Is Preoperative Assessment and Treatment of Asymptomatic Bacteriuria Necessary for Reducing the Risk of Postoperative Symptomatic Urinary Tract Infections After Urologic Surgical Procedures?
    Urology, 99, 100-105
    DOI 10.1016/j.urology.2016.10.016, PubMed 27773650
  11. Drejer D, Béji S, Oezeke R, Nielsen AM, Høyer S, Bjerklund Johansen TE, Lam GW, Jensen JB (2016)
    Comparison of White Light, Photodynamic Diagnosis, and Narrow-band Imaging in Detection of Carcinoma In Situ or Flat Dysplasia at Transurethral Resection of the Bladder: the DaBlaCa-8 Study
    Urology, 102, 138-142
    DOI 10.1016/j.urology.2016.11.032, PubMed 27894979
  12. Fosså SD, Storås AH, Steinsvik EA, Myklebust TA, Eri LM, Loge JH, Dahl AA (2016)
    Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26)
    Scand J Urol, 50 (4), 280-5
    DOI 10.3109/21681805.2016.1163617, PubMed 27049891
  13. Johansen TEB, Naber KG (2016)
    Working on a Dream
    Eur. Urol. Suppl., 15 (4), 69-70
  14. Kulchavenya E, Naber K, Johansen TEB (2016)
    Urogenital Tuberculosis: Classification, Diagnosis, and Treatment
    Eur. Urol. Suppl., 15 (4), 112-121
  15. Moen LV, Ramberg H, Zhao S, Grytli HH, Sveen A, Berge V, Skotheim RI, Taskén KA, Skålhegg BS (2016)
    Observed correlation between the expression levels of catalytic subunit, Cβ2, of cyclic adenosine monophosphate-dependent protein kinase and prostate cancer aggressiveness
    Urol Oncol, 35 (3), 111.e1-111.e8
    DOI 10.1016/j.urolonc.2016.10.002, PubMed 27838142
  16. Novak J, Vik V, Zachoval R, Bjerklund Johansen TE (2016)
    Renal Abscess Caused by Extended-Spectrum Beta-Lactamase-Producing Bacteria and Complicated by the Perforation to a Cyst and to the Renal Pelvis
    J Endourol Case Rep, 2 (1), 123-6
    DOI 10.1089/cren.2016.0022, PubMed 27579439
  17. Ramberg H, Grytli HH, Nygård S, Wang W, Ögren O, Zhao S, Løvf M, Katz B, Skotheim RI, Bjartell A, Eri LM, Berge V, Svindland A, Taskén KA (2016)
    PBX3 is a putative biomarker of aggressive prostate cancer
    Int J Cancer, 139 (8), 1810-20
    DOI 10.1002/ijc.30220, PubMed 27273830
  18. Ross-Adams H, Ball S, Lawrenson K, Halim S, Russell R, Wells C, Strand SH, Ørntoft TF, Larson M, Armasu S, Massie CE, Asim M, Mortensen MM, Borre M, Woodfine K, Warren AY, Lamb AD, Kay J, Whitaker H, Ramos-Montoya A, Murrell A, Sørensen KD, Fridley BL, Goode EL, Gayther SA et al. (2016)
    HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer
    Oncotarget, 7 (46), 74734-74746
    DOI 10.18632/oncotarget.12543, PubMed 27732966
  19. Rud E, Baco E (2016)
    Re: Jeffrey C. Weinreb, Jelle O. Barentsz, Peter L. Choyke, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69:16-40: Is Contrast-enhanced Magnetic Resonance Imaging Really Necessary When Searching for Prostate Cancer?
    Eur Urol, 70 (5), e136
    DOI 10.1016/j.eururo.2016.04.017, PubMed 27126376
  20. Skotland T, Ekroos K, Kauhanen D, Simolin H, Seierstad T, Berge V, Sandvig K, Llorente A (2016)
    Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers
    Eur J Cancer, 70, 122-132
    DOI 10.1016/j.ejca.2016.10.011, PubMed 27914242
  21. Smelov V, Naber K, Bjerklund Johansen TE (2016)
    Letter to the Editor: Diagnostic Criteria in Urological Diseases do not Always Match with Findings by Extended Culture Techniques and Metagenomic Sequencing of 16S rDNA
    Open Microbiol J, 10, 23-6
    DOI 10.2174/1874285801610010023, PubMed 27006726
  22. Smelov V, Naber K, Johansen TEB (2016)
    Improved Classification of Urinary Tract Infection: Future Considerations
    Eur. Urol. Suppl., 15 (4), 71-80
  23. Tandstad T, Ståhl O, Dahl O, Haugnes HS, Håkansson U, Karlsdottir Å, Kjellman A, Langberg CW, Laurell A, Oldenburg J, Solberg A, Söderström K, Stierner U, Cavallin-Ståhl E, Wahlqvist R, Wall N, Cohn-Cedermark G, SWENOTECA (2016)
    Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)
    Ann Oncol, 27 (7), 1299-304
    DOI 10.1093/annonc/mdw164, PubMed 27052649
  24. Vahlensieck W, Perepanova T, Johansen TEB, Tenke P, Naber KG, Wagenlehner FME (2016)
    Management of Uncomplicated Recurrent Urinary Tract Infections
    Eur. Urol. Suppl., 15 (4), 95-101
  25. Wang L, Skotland T, Berge V, Sandvig K, Llorente A (2016)
    Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validation
    Eur J Pharm Sci, 98, 80-85
    DOI 10.1016/j.ejps.2016.09.023, PubMed 27664330
  26. Østby-Deglum M, Axcrona K, Brennhovd B, Dahl AA (2016)
    Ability to Reach Orgasm in Patients With Prostate Cancer Treated With Robot-assisted Laparoscopic Prostatectomy
    Urology, 92, 38-43
    DOI 10.1016/j.urology.2015.11.066, PubMed 26972145

Publications 2015

  1. Andreassen OA, Desikan RS, Wang Y, Thompson WK, Schork AJ, Zuber V, Doncheva NT, Ellinghaus E, Albrecht M, Mattingsdal M, Franke A, Lie BA, Mills IG, Aukrust P, McEvoy LK, Djurovic S, Karlsen TH, Dale AM (2015)
    Abundant genetic overlap between blood lipids and immune-mediated diseases indicates shared molecular genetic mechanisms
    PLoS One, 10 (4), e0123057
    DOI 10.1371/journal.pone.0123057, PubMed 25853426
  2. Asim M, Massie CE, Orafidiya F, Pértega-Gomes N, Warren AY, Esmaeili M, Selth LA, Zecchini HI, Luko K, Qureshi A, Baridi A, Menon S, Madhu B, Escriu C, Lyons S, Vowler SL, Zecchini VR, Shaw G, Hessenkemper W, Russell R, Mohammed H, Stefanos N, Lynch AG, Grigorenko E, D'Santos C et al. (2015)
    Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target
    J Natl Cancer Inst, 108 (5)
    DOI 10.1093/jnci/djv371, PubMed 26657335
  3. Baco E, Rud E, Eri L, Oen G, Latkovic L, Svindland A, Eggesbø H, Ukimura O (2015)
    [Not Available]
    Prog Urol, 25 (13), 832-3
    DOI 10.1016/j.purol.2015.08.231, PubMed 26544425
  4. Baco E, Rud E, Eri LM, Moen G, Vlatkovic L, Svindland A, Eggesbø HB, Ukimura O (2015)
    A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy
    Eur Urol, 69 (1), 149-56
    DOI 10.1016/j.eururo.2015.03.041, PubMed 25862143
  5. Barfeld SJ, Fazli L, Persson M, Marjavaara L, Urbanucci A, Kaukoniemi KM, Rennie PS, Ceder Y, Chabes A, Visakorpi T, Mills IG (2015)
    Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer
    Oncotarget, 6 (14), 12587-602
    DOI 10.18632/oncotarget.3494, PubMed 25869206
  6. Bartoletti R, Cai T, Perletti G, M E Wagenlehner F, Bjerklund Johansen TE (2015)
    Finafloxacin for the treatment of urinary tract infections
    Expert Opin Investig Drugs, 24 (7), 957-63
    DOI 10.1517/13543784.2015.1052401, PubMed 26068714
  7. Bigot P, Bernhard JC, Gill IS, Vuong NS, Verhoest G, Flamand V, Reix B, Suer E, Gökce I, Beauval JB, Nouhaud FX, Eto M, Baco E, Matsugasumi T, Chowaniec Y, Rigaud J, Lenormand C, Pfister C, Hetet JF, Ploussard G, Roupret M, Léon P, Bakri AE, Larré S, Tillou X et al. (2015)
    The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery
    World J Urol, 34 (3), 347-52
    DOI 10.1007/s00345-015-1634-0, PubMed 26149352
  8. Bollineni RC, Guldvik IJ, Grönberg H, Wiklund F, Mills IG, Thiede B (2015)
    A differential protein solubility approach for the depletion of highly abundant proteins in plasma using ammonium sulfate
    Analyst, 140 (24), 8109-17
    DOI 10.1039/c5an01560j, PubMed 26541119
  9. Cai T, Verze P, Brugnolli A, Tiscione D, Luciani LG, Eccher C, Lanzafame P, Malossini G, Wagenlehner FM, Mirone V, Bjerklund Johansen TE, Pickard R, Bartoletti R (2015)
    Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: An Important Step in Antimicrobial Stewardship
    Eur Urol, 69 (2), 276-83
    DOI 10.1016/j.eururo.2015.05.010, PubMed 26001610
  10. Eri LM (2015)
    [Re: Implementation of guidelines for PSA testing in general practice]
    Tidsskr Nor Laegeforen, 135 (1), 15
    DOI 10.4045/tidsskr.14.1494, PubMed 25589118
  11. Johansen TE (2015)
    [Different guidelines for treatment of prostate cancer]
    Tidsskr Nor Laegeforen, 135 (10), 924-5
    DOI 10.4045/tidsskr.15.0317, PubMed 26037750
  12. Johansen TE (2015)
    [Re: Different guidelines for treatment of prostate cancer]
    Tidsskr Nor Laegeforen, 135 (17), 1535-6
    DOI 10.4045/tidsskr.15.0928, PubMed 26394579
  13. Johansen TE (2015)
    [Re: The problematical prostate cancer]
    Tidsskr Nor Laegeforen, 135 (17), 1536
    DOI 10.4045/tidsskr.15.0915, PubMed 26394580
  14. Lund K, Dembinski JL, Solberg N, Urbanucci A, Mills IG, Krauss S (2015)
    Slug-dependent upregulation of L1CAM is responsible for the increased invasion potential of pancreatic cancer cells following long-term 5-FU treatment
    PLoS One, 10 (4), e0123684
    DOI 10.1371/journal.pone.0123684, PubMed 25860483
  15. Mouraviev V, Lee B, Patel V, Albala D, Johansen TE, Partin A, Ross A, Perera RJ (2015)
    Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer
    Prostate Cancer Prostatic Dis, 19 (1), 14-20
    DOI 10.1038/pcan.2015.48, PubMed 26503110
  16. Rud E, Baco E, Klotz D, Rennesund K, Svindland A, Berge V, Lundeby E, Wessel N, Hoff JR, Berg RE, Diep L, Eggesbø HB, Eri LM (2015)
    Does preoperative magnetic resonance imaging reduce the rate of positive surgical margins at radical prostatectomy in a randomised clinical trial?
    Eur Urol, 68 (3), 487-96
    DOI 10.1016/j.eururo.2015.02.039, PubMed 25813692
  17. Seglen PO, Luhr M, Mills IG, Sætre F, Szalai P, Engedal N (2015)
    Macroautophagic cargo sequestration assays
    Methods, 75, 25-36
    DOI 10.1016/j.ymeth.2014.12.021, PubMed 25576638
  18. Sevilla LM, Latorre V, Carceller E, Boix J, Vodák D, Mills IG, Pérez P (2015)
    Glucocorticoid receptor and Klf4 co-regulate anti-inflammatory genes in keratinocytes
    Mol Cell Endocrinol, 412, 281-9
    DOI 10.1016/j.mce.2015.05.015, PubMed 26001834
  19. Shaw GL, Whitaker H, Corcoran M, Dunning MJ, Luxton H, Kay J, Massie CE, Miller JL, Lamb AD, Ross-Adams H, Russell R, Nelson AW, Eldridge MD, Lynch AG, Ramos-Montoya A, Mills IG, Taylor AE, Arlt W, Shah N, Warren AY, Neal DE (2015)
    The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer
    Eur Urol, 70 (2), 214-8
    DOI 10.1016/j.eururo.2015.10.042, PubMed 26572708
  20. Sheng X, Arnoldussen YJ, Storm M, Tesikova M, Nenseth HZ, Zhao S, Fazli L, Rennie P, Risberg B, Wæhre H, Danielsen H, Mills IG, Jin Y, Hotamisligil G, Saatcioglu F (2015)
    Divergent androgen regulation of unfolded protein response pathways drives prostate cancer
    EMBO Mol Med, 7 (6), 788-801
    DOI 10.15252/emmm.201404509, PubMed 25864123
  21. Solberg A, Angelsen A, Berge V, Lilleby W, Iversen J, Klepp O, Brennhovd B, Johannessen D, Nygård Y, Larsen K, Stensvold A (2015)
    [Re: Different guidelines for treatment of prostate cancer]
    Tidsskr Nor Laegeforen, 135 (12-13), 1105
    DOI 10.4045/tidsskr.15.0652, PubMed 26130530
  22. Szalai P, Hagen LK, Sætre F, Luhr M, Sponheim M, Øverbye A, Mills IG, Seglen PO, Engedal N (2015)
    Autophagic bulk sequestration of cytosolic cargo is independent of LC3, but requires GABARAPs
    Exp Cell Res, 333 (1), 21-38
    DOI 10.1016/j.yexcr.2015.02.003, PubMed 25684710
  23. Tandstad T, Ståhl O, Håkansson U, Wahlqvist R, Klepp O, Cavallin-Ståhl E, Cohn-Cedermark G, SWENOTECA (2015)
    The SWENOTECA group: A good example of continuous binational and multidisciplinary collaboration for patients with testicular cancer in Sweden and Norway
    Scand J Urol, 50 (1), 9-13
    DOI 10.3109/21681805.2015.1059360, PubMed 26116316
  24. Østby-Deglum M, Brennhovd B, Axcrona K, Fosså SD, Dahl AA (2015)
    A comparative study of erectile function and use of erectile aids in high-risk prostate cancer patients after robot-assisted laparoscopic prostatectomy
    Scand J Urol, 49 (6), 433-439
    DOI 10.3109/21681805.2015.1042038, PubMed 26116048
  25. Øverbye A, Skotland T, Koehler CJ, Thiede B, Seierstad T, Berge V, Sandvig K, Llorente A (2015)
    Identification of prostate cancer biomarkers in urinary exosomes
    Oncotarget, 6 (30), 30357-76
    DOI 10.18632/oncotarget.4851, PubMed 26196085

Publications 2014

  1. Ahmed HU, Berge V, Bottomley D, Cross W, Heer R, Kaplan R, Leslie T, Parker C, Relton C, Stephens R, Sydes MR, Turnbull L, van der Meulen J, Vickers A, Wilt T, Emberton M, Prostate Cancer RCT Consensus Group (2014)
    Can we deliver randomized trials of focal therapy in prostate cancer?
    Nat Rev Clin Oncol, 11 (8), 482-91
    DOI 10.1038/nrclinonc.2014.44, PubMed 24751803
  2. Andreassen OA, Zuber V, Thompson WK, Schork AJ, Bettella F, PRACTICAL Consortium, CRUK GWAS, Djurovic S, Desikan RS, Mills IG, Dale AM (2014)
    Shared common variants in prostate cancer and blood lipids
    Int J Epidemiol, 43 (4), 1205-14
    DOI 10.1093/ije/dyu090, PubMed 24786909
  3. Baco E, Gelet A, Crouzet S, Rud E, Rouvière O, Tonoli-Catez H, Berge V, Chapelon JY, Eggesbø HB (2014)
    Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study
    BJU Int, 114 (4), 532-40
    DOI 10.1111/bju.12545, PubMed 24930692
  4. Baco E, Ukimura O, Rud E, Vlatkovic L, Svindland A, Aron M, Palmer S, Matsugasumi T, Marien A, Bernhard JC, Rewcastle JC, Eggesbø HB, Gill IS (2014)
    Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients
    Eur Urol, 67 (4), 787-94
    DOI 10.1016/j.eururo.2014.08.077, PubMed 25240973
  5. Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, Assel M, Foster CS, Mitchell G, Drew K, Mæhle L, Axcrona K, Evans DG, Bulman B, Eccles D, McBride D, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Selkirk C, Hulick PJ, Bojesen A et al. (2014)
    Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study
    Eur Urol, 66 (3), 489-99
    DOI 10.1016/j.eururo.2014.01.003, PubMed 24484606
  6. Barfeld SJ, Itkonen HM, Urbanucci A, Mills IG (2014)
    Androgen-regulated metabolism and biosynthesis in prostate cancer
    Endocr Relat Cancer, 21 (4), T57-66
    DOI 10.1530/ERC-13-0515, PubMed 24497572
  7. Bon H, Wadhwa K, Schreiner A, Osborne M, Carroll T, Ramos-Montoya A, Ross-Adams H, Visser M, Hoffmann R, Ahmed AA, Neal DE, Mills IG (2014)
    Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancer
    Mol Cancer Res, 13 (4), 620-635
    DOI 10.1158/1541-7786.MCR-13-0182-T, PubMed 25548099
  8. Dahl S, Loge JH, Berge V, Dahl AA, Cvancarova M, Fosså SD (2014)
    Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery
    J Cancer Surviv, 9 (2), 172-9
    DOI 10.1007/s11764-014-0399-6, PubMed 25216609
  9. Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S, Bottomley D, Eggener S, Ehdaie B, Emberton M, Hindley R, Leslie T, Miners A, McCartan N, Moore CM, Pinto P, Polascik TJ, Simmons L, van der Meulen J, Villers A, Willis S, Ahmed HU (2014)
    Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting
    Eur Urol, 67 (4), 771-7
    DOI 10.1016/j.eururo.2014.09.018, PubMed 25281389
  10. Engedal N, Mills IG (2014)
    Endosomal signaling and oncogenesis
    Methods Enzymol, 535, 179-200
    DOI 10.1016/B978-0-12-397925-4.00012-2, PubMed 24377925
  11. Holm HV, Fosså SD, Hedlund H, Schultz A, Dahl AA (2014)
    Severe postprostatectomy incontinence: Is there an association between preoperative urodynamic findings and outcome of incontinence surgery?
    Scand J Urol, 49 (3), 250-9
    DOI 10.3109/21681805.2014.980845, PubMed 25428752
  12. Holm HV, Fosså SD, Hedlund H, Schultz A, Dahl AA (2014)
    How should continence and incontinence after radical prostatectomy be evaluated? A prospective study of patient ratings and changes with time
    J Urol, 192 (4), 1155-61
    DOI 10.1016/j.juro.2014.03.113, PubMed 24727062
  13. Itkonen HM, Engedal N, Babaie E, Luhr M, Guldvik IJ, Minner S, Hohloch J, Tsourlakis MC, Schlomm T, Mills IG (2014)
    UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation
    Oncogene, 34 (28), 3744-50
    DOI 10.1038/onc.2014.307, PubMed 25241896
  14. Johansen TE, Naber KG (2014)
    Urinary Tract Infections
    Antibiotics (Basel), 3 (3), 375-7
    DOI 10.3390/antibiotics3030375, PubMed 27025751
  15. Mills IG (2014)
    Maintaining and reprogramming genomic androgen receptor activity in prostate cancer
    Nat Rev Cancer, 14 (3), 187-98
    DOI 10.1038/nrc3678, PubMed 24561445
  16. Mills IG (2014)
    HOXB13, RFX6 and prostate cancer risk
    Nat Genet, 46 (2), 94-5
    DOI 10.1038/ng.2881, PubMed 24473320
  17. Nilsson R, Omland H, Dahl AA, Johansen TE (2014)
    Early outcome of orchiopexy and analysis of predictive factors: a retrospective study from 2001 to 2010 in a Norwegian regional hospital
    Scand J Urol, 48 (5), 474-81
    DOI 10.3109/21681805.2014.905631, PubMed 24720831
  18. Ragnum HB, Vlatkovic L, Lie AK, Axcrona K, Julin CH, Frikstad KM, Hole KH, Seierstad T, Lyng H (2014)
    The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
    Br J Cancer, 112 (2), 382-90
    DOI 10.1038/bjc.2014.604, PubMed 25461803
  19. Ramos-Montoya A, Lamb AD, Russell R, Carroll T, Jurmeister S, Galeano-Dalmau N, Massie CE, Boren J, Bon H, Theodorou V, Vias M, Shaw GL, Sharma NL, Ross-Adams H, Scott HE, Vowler SL, Howat WJ, Warren AY, Wooster RF, Mills IG, Neal DE (2014)
    HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network
    EMBO Mol Med, 6 (5), 651-61
    DOI 10.1002/emmm.201303581, PubMed 24737870
  20. Rud E, Baco E, Lien D, Klotz D, Eggesbø HB (2014)
    Detection of radiorecurrent prostate cancer using diffusion-weighted imaging and targeted biopsies
    AJR Am J Roentgenol, 202 (3), W241-6
    DOI 10.2214/AJR.12.10483, PubMed 24555620
  21. Rud E, Klotz D, Rennesund K, Baco E, Berge V, Lien D, Svindland A, Lundeby E, Berg RE, Eri LM, Eggesbø HB (2014)
    Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone
    BJU Int, 114 (6b), E32-E42
    DOI 10.1111/bju.12637, PubMed 24447606
  22. Rud E, Klotz D, Rennesund K, Baco E, Johansen TE, Diep LM, Svindland A, Eri LM, Eggesbø HB (2014)
    Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer
    World J Urol, 33 (7), 1015-21
    DOI 10.1007/s00345-014-1362-x, PubMed 25059766
  23. Salji M, Jones R, Paul J, Birrell F, Dixon-Hughes J, Hutchison C, Johansen TE, Greene D, Parr N, Leung HY, Cryotherapy in Prostate Cancer (CROP) study team (2014)
    Feasibility study of a randomised controlled trial to compare (deferred) androgen deprivation therapy and cryotherapy in men with localised radiation-recurrent prostate cancer
    Br J Cancer, 111 (3), 424-9
    DOI 10.1038/bjc.2014.316, PubMed 24946001
  24. Schultz A, Boye B, Jonsson O, Thind P, Månsson W (2014)
    Urostomy and health-related quality of life in patients with lower urinary tract dysfunction
    Scand J Urol, 49 (1), 2-7
    DOI 10.3109/21681805.2013.876095, PubMed 25370732
  25. Servoll E, Sæter T, Vlatkovic L, Nesland JM, Waaler G, Axcrona K (2014)
    Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience
    Scand J Urol, 49 (3), 218-23
    DOI 10.3109/21681805.2014.982168, PubMed 25428750
  26. Servoll E, Vlatkovic L, Sæter T, Nesland JM, Axcrona U, Waaler G, Axcrona K (2014)
    The length of a positive surgical margin is of prognostic significance in patients with clinically localized prostate cancer treated with radical prostatectomy
    Urol Int, 93 (3), 289-95
    DOI 10.1159/000362342, PubMed 25170745
  27. Sharma NL, Massie CE, Butter F, Mann M, Bon H, Ramos-Montoya A, Menon S, Stark R, Lamb AD, Scott HE, Warren AY, Neal DE, Mills IG (2014)
    The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer
    Nucleic Acids Res, 42 (10), 6256-69
    DOI 10.1093/nar/gku281, PubMed 24753418
  28. Siddiqui H, Lagesen K, Nederbragt AJ, Eri LM, Jeansson SL, Jakobsen KS (2014)
    Pathogens in Urine from a Female Patient with Overactive Bladder Syndrome Detected by Culture-independent High Throughput Sequencing: A Case Report
    Open Microbiol J, 8, 148-53
    DOI 10.2174/1874285801408010148, PubMed 25685246
  29. Tandstad T, Ståhl O, Håkansson U, Dahl O, Haugnes HS, Klepp OH, Langberg CW, Laurell A, Oldenburg J, Solberg A, Söderström K, Cavallin-Ståhl E, Stierner U, Wahlquist R, Wall N, Cohn-Cedermark G, SWENOTECA (2014)
    One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group
    Ann Oncol, 25 (11), 2167-72
    DOI 10.1093/annonc/mdu375, PubMed 25114021
  30. Tenke P, Köves B, Johansen TE (2014)
    An update on prevention and treatment of catheter-associated urinary tract infections
    Curr Opin Infect Dis, 27 (1), 102-7
    DOI 10.1097/QCO.0000000000000031, PubMed 24345923
  31. Wagenlehner FM, Pilatz A, Waliszewski P, Weidner W, Johansen TE (2014)
    Reducing infection rates after prostate biopsy
    Nat Rev Urol, 11 (2), 80-6
    DOI 10.1038/nrurol.2013.322, PubMed 24418806

Publications 2013

  1. Baust JG, Gage AA, Bjerklund Johansen TE, Baust JM (2013)
    Mechanisms of cryoablation: clinical consequences on malignant tumors
    Cryobiology, 68 (1), 1-11
    DOI 10.1016/j.cryobiol.2013.11.001, PubMed 24239684
  2. Berge V, Berg RE, Hoff JR, Wessel N, Diep LM, Karlsen SJ, Eri LM (2013)
    A prospective study of transition from laparoscopic to robot-assisted radical prostatectomy: quality of life outcomes after 36-month follow-up
    Urology, 81 (4), 781-6
    DOI 10.1016/j.urology.2013.01.017, PubMed 23465150
  3. Berge V, Dickinson L, McCartan N, Hindley RG, Diep LM, Emberton M, Ahmed HU (2013)
    Morbidity associated with primary high intensity focused ultrasound and redo high intensity focused ultrasound for localized prostate cancer
    J Urol, 191 (6), 1764-9
    DOI 10.1016/j.juro.2013.12.036, PubMed 24373800
  4. Engedal N, Torgersen ML, Guldvik IJ, Barfeld SJ, Bakula D, Sætre F, Hagen LK, Patterson JB, Proikas-Cezanne T, Seglen PO, Simonsen A, Mills IG (2013)
    Modulation of intracellular calcium homeostasis blocks autophagosome formation
    Autophagy, 9 (10), 1475-90
    DOI 10.4161/auto.25900, PubMed 23970164
  5. Fosså A, Røsok BI, Kazaryan AM, Holte HJ, Brennhovd B, Westerheim O, Marangos IP, Edwin B (2013)
    Laparoscopic versus open surgery in stage I-III adrenocortical carcinoma -- a retrospective comparison of 32 patients
    Acta Oncol, 52 (8), 1771-7
    DOI 10.3109/0284186X.2013.765065, PubMed 23398621
  6. Fosså SD, Nilssen Y, Kvåle R, Hernes E, Axcrona K, Møller B (2013)
    Treatment and 5-year survival in patients with nonmetastatic prostate cancer: the Norwegian experience
    Urology, 83 (1), 146-52
    DOI 10.1016/j.urology.2013.08.081, PubMed 24238563
  7. Holm HV, Fosså SD, Hedlund H, Dahl AA (2013)
    Study of generic quality of life in patients operated on for post-prostatectomy incontinence
    Int J Urol, 20 (9), 889-95
    DOI 10.1111/iju.12077, PubMed 23418855
  8. Itkonen HM, Mills IG (2013)
    N-linked glycosylation supports cross-talk between receptor tyrosine kinases and androgen receptor
    PLoS One, 8 (5), e65016
    DOI 10.1371/journal.pone.0065016, PubMed 23724116
  9. Itkonen HM, Minner S, Guldvik IJ, Sandmann MJ, Tsourlakis MC, Berge V, Svindland A, Schlomm T, Mills IG (2013)
    O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells
    Cancer Res, 73 (16), 5277-87
    DOI 10.1158/0008-5472.CAN-13-0549, PubMed 23720054
  10. Lilleby W, Stensvold A, Mills IG, Nesland JM (2013)
    Disseminated tumor cells and their prognostic significance in nonmetastatic prostate cancer patients
    Int J Cancer, 133 (1), 149-55
    DOI 10.1002/ijc.28002, PubMed 23280694
  11. Liu Y, Sæter T, Vlatkovic L, Servoll E, Waaler G, Axcrona U, Giercksky KE, Nesland JM, Suo ZH, Axcrona K (2013)
    Dendritic and lymphocytic cell infiltration in prostate carcinoma
    Histol Histopathol, 28 (12), 1621-8
    DOI 10.14670/HH-28.1621, PubMed 23729368
  12. Liu Y, Wu X, Li X, Kvalheim G, Axcrona U, Axcrona K, Suo Z (2013)
    Blocking mtDNA replication upregulates the expression of stemness-related genes in prostate cancer cell lines
    Ultrastruct Pathol, 37 (4), 258-66
    DOI 10.3109/01913123.2013.770112, PubMed 23634795
  13. Ma Y, Liang D, Liu J, Wen JG, Servoll E, Waaler G, Sæter T, Axcrona K, Vlatkovic L, Axcrona U, Paus E, Yang Y, Zhang Z, Kvalheim G, Nesland JM, Suo Z (2013)
    SHBG is an important factor in stemness induction of cells by DHT in vitro and associated with poor clinical features of prostate carcinomas
    PLoS One, 8 (7), e70558
    DOI 10.1371/journal.pone.0070558, PubMed 23936228
  14. Schultz A (2013)
    [Ritual circumcision in the global world]
    Tidsskr Nor Laegeforen, 133 (15), 1556
    DOI 10.4045/tidsskr.13.0873, PubMed 23970256
  15. Ulvik Ø, Rennesund K, Gjengstø P, Wentzel-Larsen T, Ulvik NM (2013)
    Ureteroscopy with and without safety guide wire: should the safety wire still be mandatory?
    J Endourol, 27 (10), 1197-202
    DOI 10.1089/end.2013.0248, PubMed 23795760

Publications 2012

  1. Andersen AV, Granlund P, Schultz A, Talseth T, Hedlund H, Frich L (2012)
    Long-term experience with surgical treatment of selected patients with bladder pain syndrome/interstitial cystitis
    Scand J Urol Nephrol, 46 (4), 284-9
    DOI 10.3109/00365599.2012.669789, PubMed 22452583
  2. Axcrona K, Aaltomaa S, da Silva CM, Ozen H, Damber JE, Tankó LB, Colli E, Klarskov P (2012)
    Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide
    BJU Int, 110 (11), 1721-8
    DOI 10.1111/j.1464-410X.2012.11107.x, PubMed 22500884
  3. Grisanzio C, Werner L, Takeda D, Awoyemi BC, Pomerantz MM, Yamada H, Sooriakumaran P, Robinson BD, Leung R, Schinzel AC, Mills I, Ross-Adams H, Neal DE, Kido M, Yamamoto T, Petrozziello G, Stack EC, Lis R, Kantoff PW, Loda M, Sartor O, Egawa S, Tewari AK, Hahn WC, Freedman ML (2012)
    Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis
    Proc Natl Acad Sci U S A, 109 (28), 11252-7
    DOI 10.1073/pnas.1200853109, PubMed 22730461
  4. Hart LS, Cunningham JT, Datta T, Dey S, Tameire F, Lehman SL, Qiu B, Zhang H, Cerniglia G, Bi M, Li Y, Gao Y, Liu H, Li C, Maity A, Thomas-Tikhonenko A, Perl AE, Koong A, Fuchs SY, Diehl JA, Mills IG, Ruggero D, Koumenis C (2012)
    ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth
    J Clin Invest, 122 (12), 4621-34
    DOI 10.1172/JCI62973, PubMed 23143306
  5. Hautmann RE, Abol-Enein H, Davidsson T, Gudjonsson S, Hautmann SH, Holm HV, Lee CT, Liedberg F, Madersbacher S, Manoharan M, Mansson W, Mills RD, Penson DF, Skinner EC, Stein R, Studer UE, Thueroff JW, Turner WH, Volkmer BG, Xu A, International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012 (2012)
    ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion
    Eur Urol, 63 (1), 67-80
    DOI 10.1016/j.eururo.2012.08.050, PubMed 22995974
  6. Hole KH, Axcrona K, Lie AK, Vlatkovic L, Geier OM, Brennhovd B, Knutstad K, Olsen DR, Seierstad T (2012)
    Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance
    Eur Radiol, 23 (4), 1158-66
    DOI 10.1007/s00330-012-2669-x, PubMed 23114883
  7. Lazarevic B, Hammarström C, Yang J, Ramberg H, Diep LM, Karlsen SJ, Kucuk O, Saatcioglu F, Taskèn KA, Svindland A (2012)
    The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy
    Br J Nutr, 108 (12), 2138-47
    DOI 10.1017/S0007114512000384, PubMed 22397815
  8. Lindberg J, Mills IG, Klevebring D, Liu W, Neiman M, Xu J, Wikström P, Wiklund P, Wiklund F, Egevad L, Grönberg H (2012)
    The mitochondrial and autosomal mutation landscapes of prostate cancer
    Eur Urol, 63 (4), 702-8
    DOI 10.1016/j.eururo.2012.11.053, PubMed 23265383
  9. Liu Y, Vlatkovic L, Sæter T, Servoll E, Waaler G, Nesland JM, Giercksky KE, Axcrona K (2012)
    Is the clinical malignant phenotype of prostate cancer a result of a highly proliferative immune-evasive B7-H3-expressing cell population?
    Int J Urol, 19 (8), 749-56
    DOI 10.1111/j.1442-2042.2012.03017.x, PubMed 22487487
  10. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Giercksky KE, Nesland JM, Suo Z (2012)
    Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines
    Tumour Biol, 33 (4), 967-78
    DOI 10.1007/s13277-012-0325-3, PubMed 22252524
  11. Paulo P, Ribeiro FR, Santos J, Mesquita D, Almeida M, Barros-Silva JD, Itkonen H, Henrique R, Jerónimo C, Sveen A, Mills IG, Skotheim RI, Lothe RA, Teixeira MR (2012)
    Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements
    Neoplasia, 14 (7), 600-11
    DOI 10.1593/neo.12600, PubMed 22904677
  12. Rud E, Baco E, Eggesbø HB (2012)
    MRI and ultrasound-guided prostate biopsy using soft image fusion
    Anticancer Res, 32 (8), 3383-9
    PubMed 22843919
  13. Schröder F, Crawford ED, Axcrona K, Payne H, Keane TE (2012)
    Androgen deprivation therapy: past, present and future
    BJU Int, 109 Suppl 6, 1-12
    DOI 10.1111/j.1464-410X.2012.11215.x, PubMed 22672120
  14. Sharma NL, Massie CE, Ramos-Montoya A, Zecchini V, Scott HE, Lamb AD, MacArthur S, Stark R, Warren AY, Mills IG, Neal DE (2012)
    The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man
    Cancer Cell, 23 (1), 35-47
    DOI 10.1016/j.ccr.2012.11.010, PubMed 23260764
  15. Steinsvik EA, Axcrona K, Angelsen A, Beisland C, Dahl A, Eri LM, Haug ES, Svindland A, Fosså S (2012)
    Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study
    Scand J Urol, 47 (2), 92-100
    DOI 10.3109/00365599.2012.707684, PubMed 22860630
  16. Stensvold A, Dahl AA, Brennhovd B, Småstuen MC, Fosså SD, Lilleby W, Steinsvik A, Axcrona K, Smeland S (2012)
    Bother problems in prostate cancer patients after curative treatment
    Urol Oncol, 31 (7), 1067-78
    DOI 10.1016/j.urolonc.2011.12.020, PubMed 22341412

Publications 2011

  1. Axcrona K, Vlatkovic L, Hovland J, Brennhovd B, Kongsgaard U, Giercksky KE (2011)
    Robot-assisted laparoscopic prostatectomy in a 68-year-old patient with previous heart transplantation and pelvic irradiation
    J Robot Surg, 6 (1), 81-3
    DOI 10.1007/s11701-011-0270-y, PubMed 22408687
  2. Berge V (2011)
    Editorial comment to transrectal high-intensity focused ultrasound for treatment of localized prostate cancer
    Int J Urol, 18 (5), 363-4
    DOI 10.1111/j.1442-2042.2011.02752.x, PubMed 21453400
  3. Berge V, Baco E, Dahl AA, Karlsen SJ (2011)
    Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancer
    Int J Urol, 18 (9), 646-51
    DOI 10.1111/j.1442-2042.2011.02815.x, PubMed 21771102
  4. Berge V, Berg RE, Hoff JR, Wessel N, Svindland A, Karlsen SJ, Eri LM (2011)
    Five-year progression-free survival in 577 patients operated on with laparoscopic radical prostatectomy for localized prostate cancer
    Scand J Urol Nephrol, 46 (1), 8-13
    DOI 10.3109/00365599.2011.604790, PubMed 21843041
  5. Dimmen M, Vlatkovic L, Hole KH, Nesland JM, Brennhovd B, Axcrona K (2011)
    Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies
    BJU Int, 110 (2 Pt 2), E69-75
    DOI 10.1111/j.1464-410X.2011.10759.x, PubMed 22093091
  6. Lazarevic B, Boezelijn G, Diep LM, Kvernrod K, Ogren O, Ramberg H, Moen A, Wessel N, Berg RE, Egge-Jacobsen W, Hammarstrom C, Svindland A, Kucuk O, Saatcioglu F, Taskèn KA, Karlsen SJ (2011)
    Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial
    Nutr Cancer, 63 (6), 889-98
    DOI 10.1080/01635581.2011.582221, PubMed 21714686
  7. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Stokke T, Nesland JM, Suo Z (2011)
    Prostate cancer cell lines under hypoxia exhibit greater stem-like properties
    PLoS One, 6 (12), e29170 (Retracted)
    DOI 10.1371/journal.pone.0029170, PubMed 22216200
  8. Malmström PU, Grabe M, Haug ES, Hellström P, Hermann GG, Mogensen K, Raitanen M, Wahlqvist R (2011)
    Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance
    Scand J Urol Nephrol, 46 (2), 108-16
    DOI 10.3109/00365599.2011.633279, PubMed 22087730
  9. Matsumoto T, Wagenlehner FM, Johansen TE (2011)
    Antimicrobial therapy of urinary tract infections
    Int J Antimicrob Agents, 38 Suppl, 1-2
    DOI 10.1016/j.ijantimicag.2011.09.001, PubMed 22018987
  10. Mills IG (2011)
    Nuclear translocation and functions of growth factor receptors
    Semin Cell Dev Biol, 23 (2), 165-71
    DOI 10.1016/j.semcdb.2011.09.004, PubMed 21930229
  11. Montvilas P, Solvig J, Johansen TE (2011)
    Single-centre review of radiologically guided percutaneous nephrostomy using "mixed" technique: success and complication rates
    Eur J Radiol, 80 (2), 553-8
    DOI 10.1016/j.ejrad.2011.01.109, PubMed 21353753
  12. Olofsson SE, Tandstad T, Jerkeman M, Dahl O, Ståhl O, Klepp O, Bremnes RM, Cohn-Cedermark G, Langberg CW, Laurell A, Solberg A, Stierner U, Wahlqvist R, Wijkström H, Anderson H, Cavallin-Ståhl E (2011)
    Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group
    J Clin Oncol, 29 (15), 2032-9
    DOI 10.1200/JCO.2010.29.1278, PubMed 21482994
  13. Ramberg H, Alshbib A, Berge V, Svindland A, Taskén KA (2011)
    Regulation of PBX3 expression by androgen and Let-7d in prostate cancer
    Mol Cancer, 10, 50
    DOI 10.1186/1476-4598-10-50, PubMed 21548940
  14. Rosenblatt R, Sherif A, Rintala E, Wahlqvist R, Ullén A, Nilsson S, Malmström PU, Nordic Urothelial Cancer Group (2011)
    Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer
    Eur Urol, 61 (6), 1229-38
    DOI 10.1016/j.eururo.2011.12.010, PubMed 22189383
  15. Servoll E, Saeter T, Vlatkovic L, Lund T, Nesland J, Waaler G, Axcrona K, Beisland HO (2011)
    Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer
    BJU Int, 109 (10), 1489-94
    DOI 10.1111/j.1464-410X.2011.10583.x, PubMed 21933333
  16. Steinsvik EA, Axcrona K, Dahl AA, Eri LM, Stensvold A, Fosså SD (2011)
    Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother
    BJU Int, 109 (9), 1366-74
    DOI 10.1111/j.1464-410X.2011.10598.x, PubMed 21999333
  17. Wedde TB, Lobmaier IV, Brennhovd B, Lohne F, Hall KS (2011)
    Primary Ewing's Sarcoma of the Kidney in a 73-Year-Old Man
    Sarcoma, 2011, 978319
    DOI 10.1155/2011/978319, PubMed 21776194

Publications 2010

  1. Berge V, Baco E, Karlsen SJ (2010)
    A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early results
    Scand J Urol Nephrol, 44 (4), 223-7
    DOI 10.3109/00365591003727551, PubMed 20350272
  2. Kvåle R, Møller B, Angelsen A, Dahl O, Fosså SD, Halvorsen OJ, Hoem L, Solberg A, Wahlqvist R, Bray F (2010)
    Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007
    Cancer Epidemiol, 34 (4), 359-67
    DOI 10.1016/j.canep.2010.04.017, PubMed 20627840
  3. Mitra AV, Bancroft EK, Barbachano Y, Page EC, Foster CS, Jameson C, Mitchell G, Lindeman GJ, Stapleton A, Suthers G, Evans DG, Cruger D, Blanco I, Mercer C, Kirk J, Maehle L, Hodgson S, Walker L, Izatt L, Douglas F, Tucker K, Dorkins H, Clowes V, Male A, Donaldson A et al. (2010)
    Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
    BJU Int, 107 (1), 28-39
    DOI 10.1111/j.1464-410X.2010.09648.x, PubMed 20840664
  4. Mouraviev V, Johansen TE, Polascik TJ (2010)
    Contemporary results of focal therapy for prostate cancer using cryoablation
    J Endourol, 24 (5), 827-34
    DOI 10.1089/end.2009.0546, PubMed 20443724
  5. Nøkleby K, Berge V, Stiris M, Tufteland KF, Humerfelt S (2010)
    [A 40ish man with weight loss and scrotum edema]
    Tidsskr Nor Laegeforen, 130 (20), 2026-8
    DOI 10.4045/tidsskr.09.0486, PubMed 20967042
  6. Orlin JR, Klevmark B, Bjørnsen L, Hermansen P, Sanchez M (2010)
    Two screening tests for urinary voiding dysfunction used in 209 consecutive patients undergoing lumbar spine operations
    Scand J Urol Nephrol, 44 (2), 106-12
    DOI 10.3109/00365590903544223, PubMed 20095869
  7. Røtterud R, Malmström PU, Wahlqvist R, Taskén KA (2010)
    The star chart to Ta bladder cancer: an unsophisticated analysis of two-dimensional gel electrophoresis proteome maps
    Scand J Urol Nephrol, 44 (2), 76-83
    DOI 10.3109/00365590903510729, PubMed 20059407
  8. Steinsvik EA, Fosså SD, Axcrona K, Fransson P, Widmark A, Dahl AA (2010)
    Do perceptions of adverse events differ between patients and physicians? Findings from a randomized, controlled trial of radical treatment for prostate cancer
    J Urol, 184 (2), 525-31
    DOI 10.1016/j.juro.2010.04.009, PubMed 20620412
  9. Stensvold A, Dahl AA, Fosså SD, Axcrona K, Lilleby W, Brennhovd B, Smeland S (2010)
    Clinicians' use of guidelines as illustrated by curative treatment of prostate cancer at a comprehensive cancer center
    Acta Oncol, 50 (3), 408-14
    DOI 10.3109/0284186X.2010.492236, PubMed 20586661

Publications 2009

  1. Dizeyi N, Hedlund P, Bjartell A, Tinzl M, Austild-Taskén K, Abrahamsson PA (2009)
    Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines
    Urol Oncol, 29 (4), 436-45
    DOI 10.1016/j.urolonc.2009.09.013, PubMed 19926313
  2. Fosså SD, Egey A, Haukaas SA, Angelsen A, Klepp O, Berge V, Axcrona K, Lilleby W (2009)
    [Incorrect about hormone treatment in prostatic cancer]
    Tidsskr Nor Laegeforen, 129 (5), 429
    DOI 10.4045/tidsskr.08.0649, PubMed 19247406
  3. Hernes E, Kyrdalen A, Kvåle R, Hem E, Klepp O, Axcrona K, Fosså SD (2009)
    Initial management of prostate cancer: first year experience with the Norwegian National Prostate Cancer Registry
    BJU Int, 105 (6), 805-11; discussion 811
    DOI 10.1111/j.1464-410X.2009.08834.x, PubMed 19735258
  4. Oldenburg J, Wahlqvist R, Fosså SD (2009)
    Late relapse of germ cell tumors
    World J Urol, 27 (4), 493-500
    DOI 10.1007/s00345-009-0411-3, PubMed 19373473

Publications 2008

  1. Bø K, Talseth T, Holme I (2008)
    Comment on Schiøtz et al.: Ten-year follow-up after conservative treatment of stress urinary incontinence
    Int Urogynecol J Pelvic Floor Dysfunct, 20 (2), 265
    DOI 10.1007/s00192-008-0747-z, PubMed 18941703
  2. Lazarevic B, Karlsen SJ, Saatcioglu F (2008)
    Genistein differentially modulates androgen-responsive gene expression and activates JNK in LNCaP cells
    Oncol Rep, 19 (5), 1231-5
    PubMed 18425381
  3. Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, Abrahamsson PA, Taskén KA (2008)
    Hormonal regulation of beta2-adrenergic receptor level in prostate cancer
    Prostate, 68 (10), 1133-42
    DOI 10.1002/pros.20778, PubMed 18454446
  4. Svendsen KO, Schultz A (2008)
    [Sexual dysfunction in men]
    Tidsskr Nor Laegeforen, 128 (4), 448-52
    PubMed 18274579

Publications 2007

  1. Axcrona K, Brennhovd B, Alfsen GC, Giercksky KE, Warloe T (2007)
    Photodynamic therapy with methyl aminolevulinate for atypial carcinoma in situ of the penis
    Scand J Urol Nephrol, 41 (6), 507-10
    DOI 10.1080/00365590701428590, PubMed 17853049
  2. Bakke A, Jensen KM, Jonsson O, Jónsson E, Månsson W, Paananen I, Schultz A, Thind P, Tuhkanen K (2007)
    The rationale behind recommendations for follow-up after urinary diversion: an evidence-based approach
    Scand J Urol Nephrol, 41 (4), 261-9
    DOI 10.1080/00365590600991284, PubMed 17763215
  3. Cunderlíková B, Wahlqvist R, Berner A, Vasovic V, Warloe T, Nesland JM, Peng Q (2007)
    Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples
    Cytopathology, 18 (2), 87-95
    DOI 10.1111/j.1365-2303.2007.00436.x, PubMed 17397493
  4. Karlsen SJ, Renkel J, Tahir AR, Angelsen A, Diep LM (2007)
    Extracorporeal shockwave lithotripsy versus ureteroscopy for 5- to 10-mm stones in the proximal ureter: Prospective effectiveness patient-preference trial
    J Endourol, 21 (1), 28-33
    DOI 10.1089/end.2006.0153, PubMed 17263604
  5. Kvåle R, Auvinen A, Adami HO, Klint A, Hernes E, Møller B, Pukkala E, Storm HH, Tryggvadottir L, Tretli S, Wahlqvist R, Weiderpass E, Bray F (2007)
    Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries
    J Natl Cancer Inst, 99 (24), 1881-7
    DOI 10.1093/jnci/djm249, PubMed 18073376
  6. Lilleby W, Axcrona K, Alfsen GC, Urnes T, Hole KH (2007)
    Diagnosis and treatment of primary signet-ring cell carcinoma of the prostate
    Acta Oncol, 46 (8), 1195-7
    DOI 10.1080/02841860701367886, PubMed 17851841
  7. Røtterud R, Fosså SD, Nesland JM (2007)
    Protein networking in bladder cancer: immunoreactivity for FGFR3, EGFR, ERBB2, KAI1, PTEN, and RAS in normal and malignant urothelium
    Histol Histopathol, 22 (4), 349-63
    DOI 10.14670/HH-22.349, PubMed 17290345

Publications 2006

  1. Brennhovd B, Johnsrud K, Berner A, Bogsrud T, Waehre H, Giercksky KE, Axcrona K (2006)
    Sentinel node procedure in low-stage/low-grade penile carcinomas
    Scand J Urol Nephrol, 40 (3), 204-7
    DOI 10.1080/00365590600589971, PubMed 16809260
  2. Jensen D, Aasen S, Talseth T (2006)
    Uroflowmetry with simultaneous electromyography versus voiding video cystourethrography
    Scand J Urol Nephrol, 40 (3), 232-7
    DOI 10.1080/00365590600641590, PubMed 16809266
  3. Kvissel AK, Ramberg H, Eide T, Svindland A, Skålhegg BS, Taskén KA (2006)
    Androgen dependent regulation of protein kinase A subunits in prostate cancer cells
    Cell Signal, 19 (2), 401-9
    DOI 10.1016/j.cellsig.2006.07.011, PubMed 16949795
  4. Kvåle R, Skarre E, Tønne A, Kyrdalen AE, Norstein J, Angelsen A, Wahlqvist R, Fosså SD (2006)
    [Curative treatment of prostatic cancer in Norway in 1998 and 2001]
    Tidsskr Nor Laegeforen, 126 (7), 912-6
    PubMed 16554883
  5. Nilsen FS, Haug E, Heidemann M, Karlsen SJ (2006)
    Does rapid intraoperative parathyroid hormone analysis predict cure in patients undergoing surgery for primary hyperparathyroidism? A prospective study
    Scand J Surg, 95 (1), 28-32
    DOI 10.1177/145749690609500106, PubMed 16579252
  6. Tønseth KA, Egge T, Kolbenstvedt A, Hedlund H (2006)
    Evaluation of patients after treatment of arterial priapism with selective micro-embolization
    Scand J Urol Nephrol, 40 (1), 49-52
    DOI 10.1080/00365590500338040, PubMed 16452056

Publications 2005

  1. Cek M, Lenk S, Naber KG, Bishop MC, Johansen TE, Botto H, Grabe M, Lobel B, Redorta JP, Tenke P, Members of the Urinary Tract Infection (UTI) Working Group of the European Association of Urology (EAU) Guidelines Office (2005)
    EAU guidelines for the management of genitourinary tuberculosis
    Eur Urol, 48 (3), 353-62
    DOI 10.1016/j.eururo.2005.03.008, PubMed 15982799
  2. Dizeyi N, Bjartell A, Hedlund P, Taskén KA, Gadaleanu V, Abrahamsson PA (2005)
    Expression of serotonin receptors 2B and 4 in human prostate cancer tissue and effects of their antagonists on prostate cancer cell lines
    Eur Urol, 47 (6), 895-900
    DOI 10.1016/j.eururo.2005.02.006, PubMed 15925089
  3. Fosså SD, Wahlqvist R (2005)
    [Radical treatment of prostatic cancer in Norway]
    Tidsskr Nor Laegeforen, 125 (20), 2834; author reply 2834-5
    PubMed 16244698
  4. Talseth T, Hedlund H (2005)
    [Frequent urination and fibromyalgia]
    Tidsskr Nor Laegeforen, 125 (5), 623-4; author reply 624
    PubMed 15776046
  5. Taskén KA, Angelsen A, Svindland A, Eide T, Berge V, Wahlquist R, Karlsen S (2005)
    [Markers for diagnosis, prediction and prognosis of prostate cancer]
    Tidsskr Nor Laegeforen, 125 (23), 3279-82
    PubMed 16327854
  6. Tønseth KA, Schultz A, Talseth T, Hedlund H (2005)
    [Treatment of erectile dysfunction with penile implants]
    Tidsskr Nor Laegeforen, 125 (13), 1825-7
    PubMed 16012552

Publications 2004

  1. Beisland C, Medby PC, Beisland HO (2004)
    Presumed radically treated renal cell carcinoma--recurrence of the disease and prognostic factors for subsequent survival
    Scand J Urol Nephrol, 38 (4), 299-305
    DOI 10.1080/00365590410028818, PubMed 15669589
  2. Klevmark B (2004)
    Detrusor contractility during emptying
    Scand J Urol Nephrol Suppl (215), 6-10
    DOI 10.1080/03008880410015110, PubMed 15545191
  3. Nordling J, Anjum FH, Bade JJ, Bouchelouche K, Bouchelouche P, Cervigni M, Elneil S, Fall M, Hald T, Hanus T, Hedlund H, Hohlbrugger G, Horn T, Larsen S, Leppilahti M, Mortensen S, Nagendra M, Oliveira PD, Osborne J, Riedl C, Sairanen J, Tinzl M, Wyndaele JJ (2004)
    Primary evaluation of patients suspected of having interstitial cystitis (IC)
    Eur Urol, 45 (5), 662-9
    DOI 10.1016/j.eururo.2003.11.021, PubMed 15082211
  4. Padma-Nathan H, Christ G, Adaikan G, Becher E, Brock G, Carrier S, Carson C, Corbin J, Francis S, DeBusk R, Eardley I, Hedlund H, Hutter A, Jackson G, Kloner R, Lin CS, McVary K, McCullough A, Nehra A, Porst H, Schulman C, Seftel A, Sharlip I, Stief C, Teloken C (2004)
    Pharmacotherapy for erectile dysfunction
    J Sex Med, 1 (2), 128-40
    DOI 10.1111/j.1743-6109.2004.04021.x, PubMed 16422967
  5. Seim A, Talseth T, Haukeland H, Høye K, Berg N, Bergeland T (2004)
    Validation of a simple patient questionnaire to assist self-detection of overactive bladder. A study in general practice
    Scand J Prim Health Care, 22 (4), 217-21
    DOI 10.1080/02813430410006639, PubMed 15765636

Publications 2003

  1. Eide T, Taskén KA, Carlson C, Williams G, Jahnsen T, Taskén K, Collas P (2003)
    Protein kinase A-anchoring protein AKAP95 interacts with MCM2, a regulator of DNA replication
    J Biol Chem, 278 (29), 26750-6
    DOI 10.1074/jbc.M300765200, PubMed 12740381
  2. Jichlinski P, Guillou L, Karlsen SJ, Malmström PU, Jocham D, Brennhovd B, Johansson E, Gärtner T, Lange N, van den Bergh H, Leisinger HJ (2003)
    Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study
    J Urol, 170 (1), 226-9
    DOI 10.1097/01.ju.0000060782.52358.04, PubMed 12796694
  3. Johansen TE (2003)
    [A public disease without guidelines]
    Tidsskr Nor Laegeforen, 123 (17), 2410
    PubMed 14508529
  4. Kolbenstvedt A, Jenssen G, Hedlund H (2003)
    Priapism of the glans and corpus spongiosum. Report of two cases with angiography
    Acta Radiol, 44 (4), 456-9
    DOI 10.1034/j.1600-0455.2003.00092.x, PubMed 12846700
  5. Schultz A, Hedlund H, Talseth T (2003)
    [Expandable penile implants in patients with erectile dysfunction]
    Tidsskr Nor Laegeforen, 123 (17), 2449-50
    PubMed 14562782
  6. Thiem B, Berge V (2003)
    [Cloudberry: an important source of ellagic acid, an anti-oxidant]
    Tidsskr Nor Laegeforen, 123 (13-14), 1856-7
    PubMed 12830265

Publications 2002

  1. Beisland C, Medby PC, Beisland HO (2002)
    Renal cell carcinoma: gender difference in incidental detection and cancer-specific survival
    Scand J Urol Nephrol, 36 (6), 414-8
    DOI 10.1080/003655902762467558, PubMed 12623504
  2. Dahle MK, Grønning LM, Cederberg A, Blomhoff HK, Miura N, Enerbäck S, Taskén KA, Taskén K (2002)
    Mechanisms of FOXC2- and FOXD1-mediated regulation of the RI alpha subunit of cAMP-dependent protein kinase include release of transcriptional repression and activation by protein kinase B alpha and cAMP
    J Biol Chem, 277 (25), 22902-8
    DOI 10.1074/jbc.M200131200, PubMed 11943768
  3. Dahle MK, Taskén K, Taskén KA (2002)
    USF2 inhibits C/EBP-mediated transcriptional regulation of the RIIbeta subunit of cAMP-dependent protein kinase
    BMC Mol Biol, 3, 10
    DOI 10.1186/1471-2199-3-10, PubMed 12086590
  4. Eide T, Carlson C, Taskén KA, Hirano T, Taskén K, Collas P (2002)
    Distinct but overlapping domains of AKAP95 are implicated in chromosome condensation and condensin targeting
    EMBO Rep, 3 (5), 426-32
    DOI 10.1093/embo-reports/kvf089, PubMed 11964380
  5. Eri LM, Thomassen H, Brennhovd B, Håheim LL (2002)
    Accuracy and repeatability of prostate volume measurements by transrectal ultrasound
    Prostate Cancer Prostatic Dis, 5 (4), 273-8
    DOI 10.1038/sj.pcan.4500568, PubMed 12627211
  6. Eri LM, Wessel N, Tysland O, Berge V (2002)
    Comparative study of pressure-flow parameters
    Neurourol Urodyn, 21 (3), 186-93
    DOI 10.1002/nau.10018, PubMed 11948710
  7. Frick IM, Axcrona K, Härdig Y, Tapper H, Gustafsson L, Kellner R, Leanderson T, Björck L (2002)
    Uptake and intracellular transportation of a bacterial surface protein in lymphoid cells
    Mol Microbiol, 44 (4), 917-34
    DOI 10.1046/j.1365-2958.2002.02931.x, PubMed 12010489
  8. Hedlund H (2002)
    Clinical trial designs: is it possible to have a unified approach and common end points?
    Int J Impot Res, 14 Suppl 1, S35-7
    DOI 10.1038/sj.ijir.3900794, PubMed 11850733
  9. Hedlund H, Schultz A, Talseth T, Tonseth K, van der Hagen A (2002)
    Sacral neuromodulation in Norway: clinical experience of the first three years
    Scand J Urol Nephrol Suppl (210), 87-95
    DOI 10.1080/003655902320766024, PubMed 12475023
  10. Iversen P, Tammela TL, Vaage S, Lukkarinen O, Lodding P, Bull-Njaa T, Viitanen J, Hoisaeter P, Lundmo P, Rasmussen F, Johansson JE, Persson BE, Carroll K, Scandinavian Prostatic Cancer Group (SPCG) (2002)
    A randomised comparison of bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer. First report from the Scandinavian Prostatic Cancer Group Study No. 6
    Eur Urol, 42 (3), 204-11
    DOI 10.1016/s0302-2838(02)00311-1, PubMed 12234503
  11. Johansen TE (2002)
    [Renal cancer in a 20-year perspective]
    Tidsskr Nor Laegeforen, 122 (25), 2430
    PubMed 12448108
  12. Johansen TE (2002)
    [Ritual circumcision]
    Tidsskr Nor Laegeforen, 122 (1), 15
    PubMed 11851285
  13. Klevmark B (2002)
    Volume threshold for micturition. Influence of filling rate on sensory and motor bladder function
    Scand J Urol Nephrol Suppl (210), 6-10
    DOI 10.1080/003655902320765890, PubMed 12475010

Publications 2001

  1. Argiolas A, Hedlund H (2001)
    The pharmacology and clinical pharmacokinetics of apomorphine SL
    BJU Int, 88 Suppl 3, 18-21
    DOI 10.1046/j.1464-4096.2001.00124.x, PubMed 11578274
  2. Bø K, Lilleås F, Talseth T, Hedland H (2001)
    Dynamic MRI of the pelvic floor muscles in an upright sitting position
    Neurourol Urodyn, 20 (2), 167-74
    DOI 10.1002/1520-6777(2001)20:2<167::aid-nau19>;2-4, PubMed 11170191
  3. Dahle MK, Knutsen HK, Taskén KA, Pilz R, Taskén K (2001)
    Cyclic AMP regulates expression of the RI alpha subunit of cAMP-dependent protein kinase through an alternatively spliced 5' UTR
    Eur J Biochem, 268 (22), 5920-9
    DOI 10.1046/j.0014-2956.2001.02542.x, PubMed 11722580
  4. Dahle MK, Reinton N, Orstavik S, Taskén KA, Taskén K (2001)
    Novel alternatively spliced mRNA (1c) of the protein kinase A RIα subunit is implicated in haploid germ cell specific expression
    Mol Reprod Dev, 59 (1), 11-6
    DOI 10.1002/mrd.1001, PubMed 11335941
  5. Eri LM, Sivertsen S, Nagelhus J (2001)
    The impact of participation in a study of medical treatment of lower urinary tract symptoms on the incidence of prostate surgery
    World J Urol, 19 (4), 256-8
    DOI 10.1007/s003450000180, PubMed 11550784
  6. Eri LM, Svindland A, Tveter KJ (2001)
    The effect of bicalutamide on prostate histology
    Prostate, 46 (4), 275-80
    DOI 10.1002/1097-0045(20010301)46:4<275::aid-pros1033>;2-2, PubMed 11241549
  7. Eri LM, Tveter KJ (2001)
    Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH)
    Prostate Cancer Prostatic Dis, 4 (3), 173-177
    DOI 10.1038/sj.pcan.4500504, PubMed 12497037
  8. Eri LM, Wessel N, Berge V (2001)
    Test-retest variation of pressure flow parameters in men with bladder outlet obstruction
    J Urol, 165 (4), 1188-92
    DOI 10.1016/S0022-5347(05)66466-X, PubMed 11257668
  9. Fosså SD, Eri LM, Skovlund E, Tveter K, Vatten L, Norwegian Urological Cancer Group (2001)
    No randomised trial of prostate-cancer screening in Norway
    Lancet Oncol, 2 (12), 741-5; discussion 746-9
    DOI 10.1016/S1470-2045(01)00588-5, PubMed 11902516
  10. Hedlund H, Bø K, Lilleås F, Talseth T, Tillung T (2001)
    The clinical value of dynamic magnetic resonance imaging in normal and incontinent women--a preliminary study on micturition
    Scand J Urol Nephrol Suppl (207), 87-91; discussion 106-25
    DOI 10.1080/003655901750174999, PubMed 11409620
  11. Hedlund H, Hjelmås K, Jonsson O, Klarskov P, Talja M (2001)
    Hydrophilic versus non-coated catheters for intermittent catheterization
    Scand J Urol Nephrol, 35 (1), 49-53
    DOI 10.1080/00365590151030822, PubMed 11291688
  12. Jensen KM, Månsson W, Bakke A, Jonsson E, Jonsson O, Lindell O, Schultz A, Steven K, Tuhkanen K (2001)
    Reconstructive urology in the nordic countries--a hospital questionnaire survey
    Scand J Urol Nephrol, 35 (3), 186-9
    DOI 10.1080/003655901750291935, PubMed 11487069
  13. Karlsen SJ, Bull-Njaa T, Krokstad A (2001)
    Measurement of sound emission by endoscopic lithotripters: an in vitro study and theoretical estimation of risk of hearing loss in a fetus
    J Endourol, 15 (8), 821-6
    DOI 10.1089/089277901753205825, PubMed 11724122
  14. Lindgren H, Axcrona K, Leanderson T (2001)
    Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2
    J Immunol, 166 (7), 4578-85
    DOI 10.4049/jimmunol.166.7.4578, PubMed 11254715
  15. Nilsen FS, Karlsen SJ, Gjertsen O (2001)
    Gas-containing renal stones treated with percutaneous nephrolithotomy: case report
    J Endourol, 15 (9), 915-7
    DOI 10.1089/089277901753284134, PubMed 11769846
  16. Scheepens WA, Weil EH, van Koeveringe GA, Rohrmann D, Hedlund HE, Schurch B, Ostardo E, Pastorello M, Ratto C, Nordling J, van Kerrebroeck PE (2001)
    Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation--a multicenter study
    Eur Urol, 40 (4), 434-8
    DOI 10.1159/000049812, PubMed 11713399
  17. Wessel N, Liestøl K, Maehlen J, Brorson SH (2001)
    The apolipoprotein E epsilon4 allele is no risk factor for prostate cancer in the Norwegian population
    Br J Cancer, 85 (9), 1418
    DOI 10.1054/bjoc.2001.2098, PubMed 11720484

Publications 2000

  1. Angelsen A, Talseth T, Mjønes JG, Hedlund H (2000)
    Hypertension and pseudoaneurism on the renal artery following retrograde endopyelotomy (Acucise)
    Scand J Urol Nephrol, 34 (1), 79-80
    DOI 10.1080/003655900750016977, PubMed 10757279
  2. Beisland C, Medby PC, Sander S, Beisland HO (2000)
    Nephrectomy - indications, complications and postoperative mortality in 646 consecutive patients
    Eur Urol, 37 (1), 58-64
    DOI 10.1159/000020101, PubMed 10671787
  3. Bø K, Talseth T, Vinsnes A (2000)
    Randomized controlled trial on the effect of pelvic floor muscle training on quality of life and sexual problems in genuine stress incontinent women
    Acta Obstet Gynecol Scand, 79 (7), 598-603
    DOI 10.1034/j.1600-0412.2000.079007598.x, PubMed 10929962
  4. Eri LM, Svindland A (2000)
    Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia?
    Urology, 56 (2), 261-5
    DOI 10.1016/s0090-4295(00)00629-4, PubMed 10925090
  5. Grønning LM, Wang JE, Ree AH, Haugen TB, Taskén K, Taskén KA (2000)
    Regulation of tissue inhibitor of metalloproteinases-1 in rat Sertoli cells: induction by germ cell residual bodies, interleukin-1alpha, and second messengers
    Biol Reprod, 62 (4), 1040-6
    DOI 10.1095/biolreprod62.4.1040, PubMed 10727275
  6. Hedlund H (2000)
    [Sildenafil (Viagra)--a new drug in the treatment of erectile dysfunction]
    Tidsskr Nor Laegeforen, 120 (22), 2674-5
    PubMed 11077515
  7. Nesbakken A, Nygaard K, Bull-Njaa T, Carlsen E, Eri LM (2000)
    Bladder and sexual dysfunction after mesorectal excision for rectal cancer
    Br J Surg, 87 (2), 206-10
    DOI 10.1046/j.1365-2168.2000.01357.x, PubMed 10671929
  8. Olson BJ, Skavdahl M, Ramberg H, Osterman JC, Markwell J (2000)
    Formate dehydrogenase in Arabidopsis thaliana: characterization and possible targeting to the chloroplast
    Plant Sci, 159 (2), 205-212
    DOI 10.1016/s0168-9452(00)00337-x, PubMed 11074273

Page visits: 573